It has previously been observed that C-terminal mutations in CFH are more associated with development of atypical hemolytic–uremic syndrome, and N-terminal mutations are more associated with AMD and C3 glomerulopathy.57 This evidence concerns the gene CFH and complement 3 glomerulopathy.